Virtus ETF Advisers’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-35,426
| Closed | -$333K | – | 630 |
|
|
2024
Q4 | $333K | Sell |
35,426
-2,960
| -8% | -$27.9K | 0.14% | 224 |
|
|
2024
Q3 | $309K | Hold |
38,386
| – | – | 0.14% | 228 |
|
|
2024
Q2 | $326K | Buy |
38,386
+3,779
| +11% | +$32K | 0.16% | 216 |
|
|
2024
Q1 | $310K | Buy |
34,607
+4,979
| +17% | +$44.7K | 0.16% | 225 |
|
|
2023
Q4 | $333K | Buy |
29,628
+396
| +1% | +$4.45K | 0.21% | 202 |
|
|
2023
Q3 | $252K | Sell |
29,232
-3,777
| -11% | -$32.6K | 0.15% | 224 |
|
|
2023
Q2 | $342K | Buy |
33,009
+5,537
| +20% | +$57.3K | 0.2% | 163 |
|
|
2023
Q1 | $298K | Buy |
27,472
+483
| +2% | +$5.24K | 0.16% | 218 |
|
|
2022
Q4 | $303K | Sell |
26,989
-520
| -2% | -$5.83K | 0.16% | 263 |
|
|
2022
Q3 | $279K | Buy |
27,509
+400
| +1% | +$4.06K | 0.11% | 282 |
|
|
2022
Q2 | $246K | Sell |
27,109
-9,250
| -25% | -$83.9K | 0.09% | 301 |
|
|
2022
Q1 | $348K | Hold |
36,359
| – | – | 0.16% | 159 |
|
|
2021
Q4 | $402K | Buy |
36,359
+11,957
| +49% | +$132K | 0.15% | 146 |
|
|
2021
Q3 | $181K | Sell |
24,402
-2,241
| -8% | -$16.6K | 0.08% | 296 |
|
|
2021
Q2 | $387K | Sell |
26,643
-6,228
| -19% | -$90.5K | 0.16% | 195 |
|
|
2021
Q1 | $671K | Buy |
32,871
+905
| +3% | +$18.5K | 0.28% | 112 |
|
|
2020
Q4 | $568K | Buy |
31,966
+8,818
| +38% | +$157K | 0.24% | 128 |
|
|
2020
Q3 | $342K | Buy |
23,148
+1,950
| +9% | +$28.8K | 0.18% | 194 |
|
|
2020
Q2 | $445K | Sell |
21,198
-5,745
| -21% | -$121K | 0.21% | 165 |
|
|
2020
Q1 | $623K | Sell |
26,943
-2,273
| -8% | -$52.6K | 0.26% | 146 |
|
|
2019
Q4 | $756K | Sell |
29,216
-14,226
| -33% | -$368K | 0.12% | 152 |
|
|
2019
Q3 | $846K | Sell |
43,442
-7,309
| -14% | -$142K | 0.17% | 153 |
|
|
2019
Q2 | $829K | Buy |
50,751
+22,139
| +77% | +$362K | 0.17% | 179 |
|
|
2019
Q1 | $649K | Buy |
28,612
+6,169
| +27% | +$140K | 1.38% | 22 |
|
|
2018
Q4 | $574K | Sell |
22,443
-9,783
| -30% | -$250K | 0.1% | 57 |
|
|
2018
Q3 | $1.05M | Buy |
32,226
+2,171
| +7% | +$70.9K | 0.11% | 45 |
|
|
2018
Q2 | $682K | Sell |
30,055
-2,934
| -9% | -$66.6K | 0.6% | 106 |
|
|
2018
Q1 | $800K | Sell |
32,989
-1,940
| -6% | -$47K | 0.69% | 72 |
|
|
2017
Q4 | $974K | Buy |
34,929
+7,283
| +26% | +$203K | 1.22% | 26 |
|
|
2017
Q3 | $947K | Hold |
27,646
| – | – | 0.13% | 64 |
|
|
2017
Q2 | $1.1M | Sell |
27,646
-5,808
| -17% | -$231K | 0.16% | 49 |
|
|
2017
Q1 | $1.23M | Buy |
33,454
+3,217
| +11% | +$118K | 0.22% | 48 |
|
|
2016
Q4 | $964K | Buy |
30,237
+2,408
| +9% | +$76.8K | 0.29% | 57 |
|
|
2016
Q3 | $1.01M | Buy |
27,829
+3,506
| +14% | +$127K | 0.49% | 35 |
|
|
2016
Q2 | $552K | Sell |
24,323
-13,380
| -35% | -$304K | 0.41% | 36 |
|
|
2016
Q1 | $709K | Buy |
+37,703
| New | +$709K | 0.98% | 19 |
|